A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines ...

With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Outbreaks of COVID-19 ... previous strains -- has raised concerns across the world, highlighting the urgent need for an effective, safe, and multivalent vaccine. LC16m8 is an attenuated vaccinia ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

Overweight and obesity were significantly associated with memory issues and persistent headache, among other conditions.

A malaria vaccine developed by members of the University of Oxford team behind the AstraZeneca COVID-19 jab has ... answering concerns that the effectiveness of the vaccine may wane over time ...